tiprankstipranks
Trending News
More News >
Corvel (CRVL)
:CRVL
US Market

CorVel (CRVL) AI Stock Analysis

Compare
172 Followers

Top Page

CR

CorVel

(NASDAQ:CRVL)

Rating:69Neutral
Price Target:
$121.00
▲(17.65%Upside)
CorVel's strong financial performance is the most significant factor, reflecting robust growth and efficient management. However, the high P/E ratio suggests potential overvaluation, and technical indicators point to a neutral market sentiment. The absence of recent corporate events or earnings call data means these factors do not influence the score.

CorVel (CRVL) vs. SPDR S&P 500 ETF (SPY)

CorVel Business Overview & Revenue Model

Company DescriptionCorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.
How the Company Makes MoneyCorVel Corporation makes money through a variety of revenue streams centered around its core offerings in workers' compensation, auto and liability claims management, and health management services. The company charges fees for its claims management services, which include case management, bill review, and network solutions aimed at optimizing claims processing and reducing costs. Additionally, CorVel generates revenue from its proprietary software solutions that enhance data analytics and decision-making for its clients. The company also benefits from partnerships with healthcare providers and insurance carriers, which expand its reach and service offerings. Key factors contributing to CorVel's earnings include its ability to deliver cost-effective solutions, maintain a robust network of service providers, and continuously innovate its technology and service offerings to meet the evolving needs of its clientele.

CorVel Financial Statement Overview

Summary
CorVel Corporation exhibits robust financial health with strong revenue and profit growth, efficient leverage management, and solid cash flow generation. While minor fluctuations in operational efficiency and free cash flow growth warrant monitoring, the company's overall financial trajectory is positive, supporting its competitive position in the insurance brokerage industry.
Income Statement
87
Very Positive
CorVel has shown a strong upward trajectory in revenue growth, with revenue increasing consistently over the past years. The company's gross profit and net profit margins are healthy, demonstrating effective cost management and profitability. However, the slight fluctuation in EBIT and EBITDA margins suggests potential volatility in operational efficiency.
Balance Sheet
92
Very Positive
CorVel maintains a robust financial position with a very low debt-to-equity ratio, indicating prudent leverage management. The company has a strong equity ratio, suggesting financial stability and a solid asset base. High return on equity further emphasizes the company's efficiency in generating returns for shareholders.
Cash Flow
85
Very Positive
The company has demonstrated strong free cash flow generation and growth, supported by consistent operating cash flows. The operating cash flow to net income ratio indicates effective conversion of income into cash, though minor fluctuations in free cash flow growth suggest potential investment or expenditure variations.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue871.31M895.59M795.31M718.56M646.23M552.64M
Gross Profit195.16M209.73M171.69M158.26M152.11M123.62M
EBITDA138.72M120.82M121.35M109.67M108.43M82.61M
Net Income88.20M95.17M76.25M66.36M66.41M46.36M
Balance Sheet
Total Assets538.78M545.98M454.68M393.92M415.25M424.76M
Cash, Cash Equivalents and Short-Term Investments162.94M170.58M105.56M71.33M97.50M139.72M
Total Debt29.54M19.95M31.40M33.76M43.14M54.66M
Total Liabilities237.93M223.99M207.03M191.75M202.85M204.36M
Stockholders Equity300.85M321.99M247.65M202.18M212.40M220.40M
Cash Flow
Free Cash Flow82.50M91.56M70.00M55.97M37.40M77.14M
Operating Cash Flow119.64M127.31M99.24M82.29M67.22M94.38M
Investing Cash Flow-37.14M-35.76M-29.24M-26.32M-29.82M-17.24M
Financing Cash Flow-26.55M-26.54M-35.76M-82.14M-79.61M-20.64M

CorVel Technical Analysis

Technical Analysis Sentiment
Negative
Last Price102.85
Price Trends
50DMA
108.84
Negative
100DMA
110.05
Negative
200DMA
110.88
Negative
Market Momentum
MACD
-1.99
Negative
RSI
41.55
Neutral
STOCH
39.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CRVL, the sentiment is Negative. The current price of 102.85 is below the 20-day moving average (MA) of 104.64, below the 50-day MA of 108.84, and below the 200-day MA of 110.88, indicating a bearish trend. The MACD of -1.99 indicates Negative momentum. The RSI at 41.55 is Neutral, neither overbought nor oversold. The STOCH value of 39.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CRVL.

CorVel Risk Analysis

CorVel disclosed 32 risk factors in its most recent earnings report. CorVel reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

CorVel Peers Comparison

Overall Rating
UnderperformOutperform
Sector (67)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$5.29B56.2033.41%12.61%24.78%
68
Neutral
$522.90M17.1519.94%2.67%4.44%33.61%
67
Neutral
$17.01B11.909.70%3.76%11.63%-9.47%
66
Neutral
$522.90M17.3519.94%2.64%4.44%33.61%
61
Neutral
$417.99M0.82%20.41%93.09%
59
Neutral
$126.16M3.19%17.04%74.07%
46
Neutral
$65.91M0.80%13.18%97.01%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CRVL
CorVel
102.85
17.45
20.43%
CRD.A
Crawford & Company A
10.79
2.37
28.15%
EHTH
Ehealth
4.16
-0.16
-3.70%
CRD.B
Crawford & Company B
10.31
2.28
28.39%
SLQT
SelectQuote
2.42
-0.47
-16.26%
GOCO
GoHealth
5.93
-4.25
-41.75%

CorVel Corporate Events

Executive/Board Changes
CorVel Announces Leadership Transition as Founder Retires
Positive
Nov 29, 2024

CorVel Corporation announced the retirement of its founder and long-serving Chairman, V. Gordon Clemons, effective November 26, 2024. Clemons, who has been with the company since its inception, will be succeeded by Michael G. Combs, the current CEO and President. Clemons’ leadership and vision have been pivotal in shaping CorVel’s success, and he will continue to support the company as an outside consultant. This leadership transition marks a new chapter for CorVel, promising ongoing innovation and growth.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 27, 2025